|
1
|
Okamoto K and Aoki K: Development of a
strain of spontaneously hypertensive rats. Jpn Circ J. 27:282–293.
1963. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okamoto K, Yamori Y and Nagaoka A:
Establishment of the stroke-prone spontaneously hypertensive rat
(SHR). Circ Res. 34–35(Suppl I): I-143–I-153. 1974.
|
|
3
|
Ueno KI, Togashi H, Mori K, Matsumoto M,
Ohashi S, Hoshino A, Fujita T, Saito H, Minami M and Yoshioka M:
Behavioural and pharmacological relevance of stroke-prone
spontaneously hypertensive rats as an animal model of a
developmental disorder. Behav Pharmacol. 13:1–13. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamamoto H, Okuzaki D, Yamanishi K, Xu Y,
Watanabe Y, Yoshida M, Yamashita A, Goto N, Nishiguchi S, Shimada
K, et al: Genetic analysis of genes causing hypertension and stroke
in spontaneously hypertensive rats. Int J Mol Med. 31:1057–1065.
2013.PubMed/NCBI
|
|
5
|
Yoshida M, Watanabe Y, Yamanishi K,
Yamashita A, Yamamoto H, Okuzaki D, Shimada K, Nojima H, Yasunaga
T, Okamura H, et al: Analysis of genes causing hypertension and
stroke in spontaneously hypertensive rats: gene expression profiles
in the brain. Int J Mol Med. 33:887–896. 2014.PubMed/NCBI
|
|
6
|
Guyton AC: Abnormal renal function and
autoregulation in essential hypertension. Hypertension. 18(Suppl):
III49–III53. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
8
|
Huang DW, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
9
|
Daniel JM and Reynolds AB: The catenin
p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger
transcription factor. Mol Cell Biol. 19:3614–3623. 1999.PubMed/NCBI
|
|
10
|
Dhordain P, Albagli O, Honore N, Guidez F,
Lantoine D, Schmid M, The HD, Zelent A and Koken MH: Colocalization
and heteromerization between the two human oncogene POZ/zinc finger
proteins, LAZ3 (BCL6) and PLZF. Oncogene. 19:6240–6250. 2000.
View Article : Google Scholar
|
|
11
|
Miles RR, Crockett DK, Lim MS and
Elenitoba-Johnson KS: Analysis of BCL6-interacting proteins by
tandem mass spectrometry. Mol Cell Proteomics. 4:1898–1909. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei F, Zaprazna K, Wang J and Atchison ML:
PU.1 can recruit BCL6 to DNA to repress gene expression in germinal
center B cells. Mol Cell Biol. 29:4612–4622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vasanwala FH, Kusam S, Toney LM and Dent
AL: Repression of AP-1 function: A mechanism for the regulation of
Blimp-1 expression and B lymphocyte differentiation by the B cell
lymphoma-6 protooncogene. J Immunol. 169:1922–1929. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cox JL, Wilder PJ, Gilmore JM, Wuebben EL,
Washburn MP and Rizzino A: The SOX2-interactome in brain cancer
cells identifies the requirement of MSI2 and USP9X for the growth
of brain tumor cells. PLoS One. 8:e628572013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mansukhani A, Ambrosetti D, Holmes G,
Cornivelli L and Basilico C: Sox2 induction by FGF and FGFR2
activating mutations inhibits Wnt signaling and osteoblast
differentiation. J Cell Biol. 168:1065–1076. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fukuyama K, Ichiki T, Takeda K, Tokunou T,
Iino N, Masuda S, Ishibashi M, Egashira K, Shimokawa H, Hirano K,
et al: Downregulation of vascular angiotensin II type 1 receptor by
thyroid hormone. Hypertension. 41:598–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Azuma K, Tamura K, Shigenaga A, Wakui H,
Masuda S, Tsurumi-Ikeya Y, Tanaka Y, Sakai M, Matsuda M, Hashimoto
T, et al: Novel regulatory effect of angiotensin II type 1
receptor-interacting molecule on vascular smooth muscle cells.
Hypertension. 50:926–932. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Q, Wang G, Zhou G, Tan Y, Wang X, Wei
W, Liu L, Xue W, Feng W and Cai L: Angiotensin II-induced
p53-dependent cardiac apoptotic cell death: its prevention by
metallothionein. Toxicol Lett. 191:314–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Yuan Y, Zhou Y, Guo L, Zhang L,
Kuai X, Deng B, Pan Z, Li D and He F: Protein interaction data set
highlighted with human Ras-MAPK/PI3K signaling pathways. J Proteome
Res. 7:3879–3889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Scotet V, De Braekeleer M, Audrézet MP,
Lodé L, Verlingue C, Quéré I, Mercier B, Duguépéroux I, Codet JP,
Moineau MP, et al: Prevalence of CFTR mutations in
hypertrypsinaemia detected through neonatal screening for cystic
fibrosis. Clin Genet. 59:42–47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lempinen M, Paju A, Kemppainen E, Smura T,
Kylänpää ML, Nevanlinna H, Stenman J and Stenman UH: Mutations N34S
and P55S of the SPINK1 gene in patients with chronic pancreatitis
or pancreatic cancer and in healthy subjects: a report from
Finland. Scand J Gastroenterol. 40:225–230. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gonzalez-Villalobos RA, Janjoulia T,
Fletcher NK, Giani JF, Nguyen MT, Riquier-Brison AD, Seth DM, Fuchs
S, Eladari D, Picard N, et al: The absence of intrarenal ACE
protects against hypertension. J Clin Invest. 123:2011–2023. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gumieniak O, Perlstein TS, Williams JS,
Hopkins PN, Brown NJ, Raby BA and Williams GH: Ala92 type 2
deiodinase allele increases risk for the development of
hypertension. Hypertension. 49:461–466. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Løset M, Mundal SB, Johnson MP, Fenstad
MH, Freed KA, Lian IA, Eide IP, Bjørge L, Blangero J, Moses EK and
Austgulen R: A transcriptional profile of the decidua in
preeclampsia. Am J Obstet Gynecol. 204:84.e1–84.e27. 2011.
View Article : Google Scholar
|
|
25
|
Delbosc S, Cristol JP, Descomps B, Mimran
A and Jover B: Simvastatin prevents angiotensin II-induced cardiac
alteration and oxidative stress. Hypertension. 40:142–147. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakai T, Balasubramanian K, Maiti S,
Halder JB and Schroit AJ: Plasmin-cleaved beta-2-glycoprotein 1 is
an inhibitor of angiogenesis. Am J Pathol. 171:1659–1669. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Simpkins AN, Rudic RD, Schreihofer DA, Roy
S, Manhiani M, Tsai HJ, Hammock BD and Imig JD: Soluble epoxide
inhibition is protective against cerebral ischemia via vascular and
neural protection. Am J Pathol. 174:2086–2095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thulin A, Ringvall M, Dimberg A, Kårehed
K, Väisänen T, Väisänen MR, Hamad O, Wang J, Bjerkvig R, Nilsson B,
et al: Activated platelets provide a functional microenvironment
for the antiangiogenic fragment of histidine-rich glycoprotein. Mol
Cancer Res. 7:1792–1802. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O-Uchi J, Jhun BS, Hurst S, Bisetto S,
Gross P, Chen M, Kettlewell S, Park J, Oyamada H, Smith GL, et al:
Overexpression of ryanodine receptor type 1 enhances mitochondrial
fragmentation and Ca2+- induced ATP production in
cardiac H9c2 myoblasts. Am J Physiol Heart Circ Physiol.
305:H1736–H1751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bellomo D, Headrick JP, Silins GU,
Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID,
Grimmond SM, et al: Mice lacking the vascular endothelial growth
factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary
vasculature, and impaired recovery from cardiac ischemia. Circ Res.
86:E29–E35. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strand AD, Aragaki AK, Shaw D, Bird T,
Holton J, Turner C, Tapscott SJ, Tabrizi SJ, Schapira AH,
Kooperberg C and Olson JM: Gene expression in Huntington's disease
skeletal muscle: a potential biomarker. Hum Mol Genet.
14:1863–1876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hodges A, Strand AD, Aragaki AK, Kuhn A,
Sengstag T, Hughes G, Elliston LA, Hartog C, Goldstein DR, Thu D,
et al: Regional and cellular gene expression changes in human
Huntington's disease brain. Hum Mol Genet. 15:965–977. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thomas EA: Striatal specificity of gene
expression dysregulation in Huntington's disease. J Neurosci Res.
84:1151–1164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kephart DD, Walfish PG, DeLuca H and Butt
TR: Retinoid X receptor isotype identity directs human vitamin D
receptor heterodimer transactivation from the 24-hydroxylase
vitamin D response elements in yeast. Mol Endocrinol. 10:408–419.
1996.PubMed/NCBI
|
|
35
|
Zella LA, Shevde NK, Hollis BW, Cooke NE
and Pike JW: Vitamin D-binding protein influences total circulating
levels of 1,25-dihydroxyvitamin D3 but does not directly modulate
the bioactive levels of the hormone in vivo. Endocrinology.
149:3656–3667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Norkina O, Kaur S, Ziemer D and De Lisle
RC: Inflammation of the cystic fibrosis mouse small intestine. Am J
Physiol Gastrointest Liver Physiol. 286:G1032–G1041. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fontemaggi G, Kela I, Amariglio N, Rechavi
G, Krishnamurthy J, Strano S, Sacchi A, Givol D and Blandino G:
Identification of direct p73 target genes combining DNA microarray
and chromatin immunoprecipitation analyses. J Biol Chem.
277:43359–43368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Seo E, Basu-Roy U, Zavadil J, Basilico C
and Mansukhani A: Distinct functions of Sox2 control self-renewal
and differentiation in the osteoblast lineage. Mol Cell Biol.
31:4593–4608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Senbonmatsu T, Saito T, Landon EJ,
Watanabe O, Price E Jr, Roberts RL, Imboden H, Fitzgerald TG,
Gaffney FA and Inagami T: A novel angiotensin II type 2 receptor
signaling pathway: possible role in cardiac hypertrophy. EMBO J.
22:6471–6482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
El-Shewy HM, Sohn M, Wilson P, Lee MH,
Hammad SM, Luttrell LM and Jaffa AA: Low-density lipoprotein
induced expression of connective tissue growth factor via
transactivation of sphingosine 1-phosphate receptors in mesangial
cells. Mol Endocrinol. 26:833–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kyriakis JM and Avruch J: Mammalian
mitogen-activated protein kinase signal transduction pathways
activated by stress and inflammation. Physiol Rev. 81:807–869.
2001.PubMed/NCBI
|
|
42
|
Horisawa K, Tateyama S, Ishizaka M,
Matsumura N, Takashima H, Miyamoto-Sato E, Doi N and Yanagawa H: In
vitro selection of Jun-associated proteins using mRNA display.
Nucleic Acids Res. 32:e1692004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rao S, Matsumura A, Yoon J and Simon MC:
SPI-B activates transcription via a unique proline, serine, and
threonine domain and exhibits DNA binding affinity differences from
PU.1. J Biol Chem. 274:11115–11124. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang
C, Hammock BD, Shyy JY and Zhu Y: Angiotensin II up-regulates
soluble epoxide hydrolase in vascular endothelium in vitro and in
vivo. Proc Natl Acad Sci USA. 104:9018–9023. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Toh WH, Siddique MM, Boominathan L, Lin KW
and Sabapathy K: c-Jun regulates the stability and activity of the
p53 homologue, p73. J Biol Chem. 279:44713–44722. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Canettieri G, Franchi A, Guardia MD,
Morantte I, Santaguida MG, Harney JW, Larsen PR and Centanni M:
Activation of thyroid hormone is transcriptionally regulated by
epidermal growth factor in human placenta-derived JEG3 cells.
Endocrinology. 149:695–702. 2008. View Article : Google Scholar
|
|
47
|
Jahan A and Chiang JY: Cytokine regulation
of human sterol 12alpha-hydroxylase (CYP8B1) gene. Am J Physiol
Gastrointest Liver Physiol. 288:G685–G695. 2005. View Article : Google Scholar
|
|
48
|
Morris JB, Pham TM, Kenney B, Sheppard KE
and Woodcock EA: UTP transactivates epidermal growth factor
receptors and promotes cardiomyocyte hypertrophy despite inhibiting
transcription of the hypertrophic marker gene, atrial natriuretic
peptide. J Biol Chem. 279:8740–8746. 2004. View Article : Google Scholar
|
|
49
|
Fontana X, Hristova M, Da Costa C, Patodia
S, Thei L, Makwana M, Spencer-Dene B, Latouche M, Mirsky R, Jessen
KR, et al: c-Jun in Schwann cells promotes axonal regeneration and
motoneuron survival via paracrine signaling. J Cell Biol.
198:127–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kinoshita I, Leaner V, Katabami M, Manzano
RG, Dent P, Sabichi A and Birrer MJ: Identification of
cJun-responsive genes in Rat-1a cells using multiple techniques:
Increased expression of stathmin is necessary for cJun-mediated
anchorage-independent growth. Oncogene. 22:2710–2722. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sinha S, Malonia SK, Mittal SP, Singh K,
Kadreppa S, Kamat R, Mukhopadhyaya R, Pal JK and Chattopadhyay S:
Coordinated regulation of p53 apoptotic targets BAX and PUMA by
SMAR1 through an identical MAR element. EMBO J. 29:830–842. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Izzotti A, Cartiglia C, Longobardi M,
Bagnasco M, Merello A, You M, Lubet RA and De Flora S: Gene
expression in the lung of p53 mutant mice exposed to cigarette
smoke. Cancer Res. 64:8566–8572. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Steffan JS, Kazantsev A, Spasic-Boskovic
O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE
and Thompson LM: The Huntington's disease protein interacts with
p53 and CREB-binding protein and represses transcription. Proc Natl
Acad Sci USA. 97:6763–6768. 2000. View Article : Google Scholar : PubMed/NCBI
|
